Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Exercise testing parameters associated with post lung transplant mortality.

Armstrong HF, Garber CE, Bartels MN.

Respir Physiol Neurobiol. 2012 Apr 30;181(2):118-22. doi: 10.1016/j.resp.2012.02.003. Epub 2012 Feb 21.

PMID:
22503816
2.

The Munich-LTX-Score: predictor for survival after lung transplantation.

Huppmann P, Neurohr C, Leuschner S, Leuchte H, Baumgartner R, Zimmermann G, Meis T, von Wulffen W, Überfuhr P, Hatz R, Frey L, Behr J; Munich Lung Transplant Group (MLTG)..

Clin Transplant. 2012 Jan-Feb;26(1):173-83. doi: 10.1111/j.1399-0012.2011.01573.x. Epub 2011 Dec 20.

PMID:
22188413
3.

Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.

Ailawadi G, Smith PW, Oka T, Wang H, Kozower BD, Daniel TM, Kron IL, Jones DR.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):594-602. doi: 10.1016/j.jtcvs.2007.10.044. Epub 2008 Jan 18.

4.

Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.

Gottlieb J, Mattner F, Weissbrodt H, Dierich M, Fuehner T, Strueber M, Simon A, Welte T.

Respir Med. 2009 May;103(5):743-9. doi: 10.1016/j.rmed.2008.11.015. Epub 2008 Dec 30.

5.

The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome.

Shitrit D, Amital A, Fox B, Kramer MR.

Respir Med. 2008 Feb;102(2):205-9. Epub 2007 Oct 31.

6.

Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?

Burton CM, Iversen M, Mortensen J, Carlsen J, Andersen CB, Milman N, Scheike T.

J Heart Lung Transplant. 2007 Nov;26(11):1127-34. Epub 2007 Sep 29.

PMID:
18022078
7.

Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.

Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA.

Ann Thorac Surg. 1995 Nov;60(5):1341-6; discussion 1346-7.

PMID:
8526624
8.

Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.

Gerbase MW, Soccal PM, Spiliopoulos A, Nicod LP, Rochat T.

J Heart Lung Transplant. 2008 Aug;27(8):898-904. doi: 10.1016/j.healun.2008.04.012. Epub 2008 Jun 10.

PMID:
18656804
9.

Long-term outcome after pulmonary retransplantation.

Strueber M, Fischer S, Gottlieb J, Simon AR, Goerler H, Gohrbandt B, Welte T, Haverich A.

J Thorac Cardiovasc Surg. 2006 Aug;132(2):407-12.

10.

Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients.

Tirdel GB, Girgis R, Fishman RS, Theodore J.

J Heart Lung Transplant. 1998 Dec;17(12):1231-7.

PMID:
9883765
11.

Limiting factors of exercise performance 1 year after lung transplantation.

Reinsma GD, ten Hacken NH, Grevink RG, van der Bij W, Koëter GH, van Weert E.

J Heart Lung Transplant. 2006 Nov;25(11):1310-6.

PMID:
17097494
12.

Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation.

Kawut SM, O'Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM.

Respir Med. 2005 Nov;99(11):1431-9.

13.

Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation.

Atkins BZ, Petersen RP, Daneshmand MA, Turek JW, Lin SS, Davis RD Jr.

Ann Thorac Surg. 2010 Nov;90(5):1622-8. doi: 10.1016/j.athoracsur.2010.06.089.

PMID:
20971276
14.

Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL.

Transplantation. 2002 Sep 27;74(6):799-804.

PMID:
12364858
15.

Pulmonary retransplantation in the Nordic countries.

Lindstedt S, Dellgren G, Iversen M, Riise GC, Bjørtuft Ø, Hämmäinen P, Skog I, Fiane A, Wierup P; Nordic Thoracic Transplantation Study Group (NTTSG)..

Ann Thorac Surg. 2015 May;99(5):1781-7. doi: 10.1016/j.athoracsur.2015.01.052. Epub 2015 Mar 29.

PMID:
25827676
16.

Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients.

Calhoun R, SivaSai KS, Sundaresan S, Trulock EP, Lynch JP, Patterson GA, Cooper JD, Mohanakumar T.

Transpl Int. 1999;12(6):439-46.

17.

The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation.

Nawrot TS, Vos R, Jacobs L, Verleden SE, Wauters S, Mertens V, Dooms C, Hoet PH, Van Raemdonck DE, Faes C, Dupont LJ, Nemery B, Verleden GM, Vanaudenaerde BM.

Thorax. 2011 Sep;66(9):748-54. doi: 10.1136/thx.2010.155192. Epub 2011 Mar 23.

PMID:
21429899
18.

Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.

Valentine VG, Robbins RC, Berry GJ, Patel HR, Reichenspurner H, Reitz BA, Theodore J.

J Heart Lung Transplant. 1996 Apr;15(4):371-83.

PMID:
8732596
19.

Long-term pulmonary function after living-donor lobar lung transplantation in adults.

Bowdish ME, Pessotto R, Barbers RG, Schenkel FA, Starnes VA, Barr ML.

Ann Thorac Surg. 2005 Feb;79(2):418-25.

PMID:
15680807
20.

Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome.

Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Willems-Widyastuti A, Scheers H, Van Raemdonck DE, Dupont LJ, Verleden GM.

J Heart Lung Transplant. 2009 Aug;28(8):799-807. doi: 10.1016/j.healun.2009.05.011.

PMID:
19632576

Supplemental Content

Support Center